Measuring emissions in clinical trials sounds technical, and it is. But this session is designed to make it relevant to you, wherever you are in your sustainability journey.

In this webinar, we’ll dive into the SHC methodology for assessing clinical trial emissions, a framework developed collaboratively with a consortium of eight pharma companies and now widely recognised across the sector. Since January 2025, the clinical research community has a consistent, credible way to assess clinical trial emissions, and begin building the data needed to define future baselines, thresholds, and carbon objectives.

We’ll hear first from Jason LaRoche (Johnson and Johnson), one of the pioneers of clinical trial emissions assessment, who will share what drew him to this work, why it matters, and his long-term vision for where the field is heading, with the SHC methodology as a crucial stepping stone along that journey. He’ll be joined by Simon Aumônier (ERM), one of the technical experts behind the methodology, who will unpack it in plain language and help everyone find their way through it, whatever their starting point.

Most importantly, this won’t stay theoretical. The heart of the session will be a real- world story from one of the members of the Community of Practice, showing how they are using the methodology in practice, what problems it helps them solve, and how it has opened new doors for collaboration, insight, and action. Expect practical takeaways, honest reflections, and a few surprises along the way.

And to close, we’ll be unveiling the new version of the clinical trials carbon calculator, with features shaped directly by the community’s feedback. If you were among those who tested the beta, let’s just say your input did not go unnoticed.

Come curious, come sceptical, come enthusiastic, and come ready for a session that proves even methodologies can be engaging when they’re grounded in real impact.